Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Goodman

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Calcified Tissue International|May 17, 2001
Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the ratS Epstein, I R Dissanayake, G R Goodman, et al.
Transplantation|February 11, 1998
Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the ratI R Dissanayake, G R Goodman, A R Bowman, et al.
Bone|October 8, 1999
Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the ratG R Goodman, I R Dissanayake, E Gorodetsky, et al.
Journal of Vascular Surgery|May 1, 1996
Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-mybR J Pitsch, G R Goodman, D J Minion, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 10, 2001
Immunosuppressant use without bone loss--implications for bone loss after transplantationG R Goodman, I R Dissanayake, B R Sodam, et al.
Bone|June 27, 2001
Transforming growth factor-beta administration modifies cyclosporine A-induced bone lossG R Goodman, I R Dissanayake, A R Bowman, et al.
Journal of Vascular Surgery|May 8, 1999
The proliferative response to platelet-derived growth factor of smooth muscle cells isolated from synthetic vascular grafts in a canine modelD J Minion, M P van de Kerkhove, G R Goodman, et al.
Frontiers in Digital Health|November 17, 2022
Media and technology usage and attitudes in emergency department patientsC E Goldfine, A Knapp, G R Goodman, et al.
Frontiers in Psychiatry|June 1, 2026
Feasibility, acceptability, and user perspective of a next-generation wrist-worn receiver and digital pills for HIV pre-exposure prophylaxis: a pilot studyDhruv Nimbalkar, G R Goodman, J Hokayem, et al.
The British Journal of Dermatology|November 30, 2018
A prospective observational safety study of patients with BRAF<sup>V</sup> <sup>600</sup> -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study)P G Corrie, P Terheyden, A J Ten Tije, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Calcified Tissue International|May 17, 2001
Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the ratS Epstein, I R Dissanayake, G R Goodman, et al.
Transplantation|February 11, 1998
Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the ratI R Dissanayake, G R Goodman, A R Bowman, et al.
Bone|October 8, 1999
Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the ratG R Goodman, I R Dissanayake, E Gorodetsky, et al.
Journal of Vascular Surgery|May 1, 1996
Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-mybR J Pitsch, G R Goodman, D J Minion, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 10, 2001
Immunosuppressant use without bone loss--implications for bone loss after transplantationG R Goodman, I R Dissanayake, B R Sodam, et al.
Bone|June 27, 2001
Transforming growth factor-beta administration modifies cyclosporine A-induced bone lossG R Goodman, I R Dissanayake, A R Bowman, et al.
Journal of Vascular Surgery|May 8, 1999
The proliferative response to platelet-derived growth factor of smooth muscle cells isolated from synthetic vascular grafts in a canine modelD J Minion, M P van de Kerkhove, G R Goodman, et al.
Frontiers in Digital Health|November 17, 2022
Media and technology usage and attitudes in emergency department patientsC E Goldfine, A Knapp, G R Goodman, et al.
Frontiers in Psychiatry|June 1, 2026
Feasibility, acceptability, and user perspective of a next-generation wrist-worn receiver and digital pills for HIV pre-exposure prophylaxis: a pilot studyDhruv Nimbalkar, G R Goodman, J Hokayem, et al.
The British Journal of Dermatology|November 30, 2018
A prospective observational safety study of patients with BRAF<sup>V</sup> <sup>600</sup> -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study)P G Corrie, P Terheyden, A J Ten Tije, et al.
Pageof 4